Skip to main content
logo
Dishman Carbogen Amcis Limited (NSE:DCAL)
India flag India · Delayed Price · Currency is INR
195.50
-16.38 (-7.73%)
May 22, 2026, 3:30 PM IST

Dishman Carbogen Amcis Revenue

In the fiscal year ending March 31, 2026, Dishman Carbogen Amcis had annual revenue of 29.88B INR with 10.19% growth. Dishman Carbogen Amcis had revenue of 8.68B in the quarter ending March 31, 2026, with 21.15% growth.

Revenue
29.88B
Revenue Growth
+10.19%
P/S Ratio
1.04
Revenue / Employee
26.51M
Employees
1,106
Market Cap
30.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202629.88B2.76B10.19%
Mar 31, 202527.12B957.30M3.66%
Mar 31, 202426.16B2.03B8.41%
Mar 31, 202324.13B2.72B12.72%
Mar 31, 202221.41B2.29B11.96%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biocon169.27B
Anthem Biosciences22.80B
OneSource Specialty Pharma14.37B
Concord Biotech11.59B
Blue Jet Healthcare10.53B
Supriya Lifescience7.35B
Panacea Biotec6.06B
Zota Health Care4.73B
Revenue Rankings

Dishman Carbogen Amcis News

More News